info icon

This is a non-core endpoint: only basic statistics are computed.

Histoplasmosis

AB1_HISTOPLASMOSIS

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 B39
  • Hospital discharge: ICD-9 115
  • Hospital discharge: ICD-8 115
  • Cause of death: ICD-10 B39
  • Cause of death: ICD-9 115
  • Cause of death: ICD-8 115

2 out of 7 registries used, show all original rules.

20

4. Check minimum number of events

None

20

5. Include endpoints

None

20

6. Filter based on genotype QC (FinnGen only)

20

Control definitions (FinnGen only)

Control exclude
AB1_MYCOSES

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF5

Case counts by codes

FinnGen case counts by registry codes:

Not enough data for upset plot.

Not enough data for upset table.

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 274 155 119
Only index persons 225 128 97
Unadjusted period prevalence (%)
Whole population 0.00 0.00 0.00
Only index persons 0.00 0.00 0.00
Median age at first event (years)
Whole population - 29.96 14.87
Only index persons 19.98 26.48 11.40

-FinnGen-

Key figures

All Female Male
Number of individuals 20 14 6
Unadjusted period prevalence (%) 0.00 0.00 0.00
Median age at first event (years) 39.44 30.91 59.37

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

No data available

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013512) EKG study
10
44
3.55
1.91
3.7
3.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
10
44
3.55
1.91
7.8
2.0
mg/l
2.9
2.5
—
10
39
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
14
80
3.48
1.80
3.7
4.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
5
14
4.38
1.73
2.8
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
5
15
4.07
1.63
1.2
1.6
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
9
44
2.88
1.53
2.6
2.7
—
—
—
0
0
(3002256) Pathology report gross observation
5
18
3.34
1.37
1.8
1.2
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
8
39
2.74
1.35
2.6
2.3
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
20
171
+∞
1.08
18.4
13.7
umol/l
72.3
71.1
0.10
20
171
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
9
55
2.15
0.91
3.2
3.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
10
62
2.23
0.85
2.4
2.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
5
23
2.55
0.83
2.2
5.4
%
38.0
31.4
—
5
18
(3003694) ABO and Rh group [Type] in Blood
8
52
1.89
0.71
1.4
1.8
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
9
61
1.86
0.68
12.6
6.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
0
20
0.00
0.64
0.0
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
20
181
+∞
0.64
12.6
10.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
6
37
1.88
0.62
1.0
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
6
38
1.82
0.61
2.5
3.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
7
47
1.75
0.56
4.4
3.9
u/l
35.0
28.2
—
7
42
(3023368) Bacteria identified in Blood by Culture
5
33
1.68
0.45
9.4
4.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
8
64
1.41
0.33
5.0
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
12
98
1.56
0.32
2.9
3.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
5
39
1.37
0.25
2.6
1.4
nmol/l
17.9
23.4
—
5
31
(1761868) Lipid panel - Serum or Plasma
6
50
1.28
0.22
2.2
2.9
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
11
0.00
0.22
0.0
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
10
0.00
0.22
0.0
1.5
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
0
12
0.00
0.22
0.0
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
0
12
0.00
0.22
0.0
3.6
—
1.2
—
0
12
(3014576) Chloride [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
11.0
—
104.2
—
0
13
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
8
66
1.35
0.21
4.1
2.6
nmol/l
99.9
76.7
—
8
56
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
0
14
0.00
0.21
0.0
14.9
—
25.4
—
0
14
(3025941) Bacteria identified in Stool by Culture
0
14
0.00
0.21
0.0
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
10
85
1.35
0.17
12.5
8.0
umol/l
10.1
9.7
—
10
79
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
15
154
0.90
0.10
2.5
4.1
mmol/l
1.2
1.5
4.13
15
146
(3002385) Erythrocyte distribution width [Ratio]
14
147
0.84
0.10
18.3
16.1
%
13.9
13.3
0.88
14
142
(3018095) Leukocytes [#/volume] in Urine
5
61
0.76
0.10
2.8
4.0
e6/l
18.9
37.0
—
5
43
(3006315) Basophils [#/volume] in Blood
9
84
1.13
0.09
17.7
6.6
e9/l
0.0
0.0
—
9
74
(3037467) Urinalysis macro (dipstick) panel - Urine
12
113
1.15
0.09
5.2
4.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
9
85
1.11
0.09
17.8
6.6
e9/l
0.6
0.5
—
9
75
(3021589) Normoblasts [#/volume] in Blood
7
76
0.88
0.00
26.6
8.2
e9/l
0.0
0.0
—
7
59
(3045414) Leukocytes [Presence] in Urine
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
20
191
+∞
0.00
26.4
18.6
e9/l
248.6
250.4
0.03
20
185
(3023511) Choriogonadotropin [Units/volume] in Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
6
60
1.00
0.00
2.8
3.4
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
0
6
0.00
0.00
0.0
19.3
—
96.7
—
0
6
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
20
192
+∞
0.00
26.5
18.5
e9/l
6.7
6.5
0.18
20
187
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
33.5
—
0
6
(3026361) Erythrocytes [#/volume] in Blood
20
192
+∞
0.00
26.4
18.5
e12/l
4.4
4.5
0.09
20
187
(3023410) Appearance of Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
0
6
0.00
0.00
0.0
6.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
0
5
0.00
0.00
0.0
22.8
—
0.8
—
0
5
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
4.1
—
24.3
—
0
8
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
0
5
0.00
0.00
0.0
22.8
—
0.7
—
0
5
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
0
6
0.00
0.00
0.0
19.5
—
12.1
—
0
6
(40758558) Short blood count panel - Blood
5
51
0.97
0.00
22.6
6.8
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
8
82
0.96
0.00
6.4
2.9
ug/l
39.0
71.6
—
8
73
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
14.0
—
0
8
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
5
51
0.97
0.00
2.4
2.8
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
0
5
0.00
0.00
0.0
1.0
—
6.2
—
0
5
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
14
139
1.02
0.00
3.7
3.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
5
47
1.08
0.00
2.6
3.2
e6/l
0.2
0.0
—
5
32
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
9
87
1.06
0.00
22.9
6.6
e9/l
1.9
1.8
—
9
78
(40768793) Breast Pathology biopsy report
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3015736) pH of Urine
6
64
0.91
0.00
2.8
2.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
0
6
0.00
0.00
0.0
19.7
—
5.4
—
0
6
(3001019) Free T4 and TSH panel - Serum or Plasma
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
5
0.00
0.00
0.0
1.8
—
239.2
—
0
5
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
383.3
—
0
7
(3014148) Varicella zoster virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
5
49
1.03
0.00
1.2
1.8
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint AB1_HISTOPLASMOSIS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have AB1_HISTOPLASMOSIS.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

Index endpoint: AB1_HISTOPLASMOSIS – Histoplasmosis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data